Resmed Inc’s filing revealed that its Director FARRELL PETER C unloaded Company’s shares for reported $0.5 million on Nov 12 ’25. In the deal valued at $252.05 per share,2,000 shares were sold. As a result of this transaction, FARRELL PETER C now holds 66,110 shares worth roughly $16.18 million.
Then, De Witte Jan sold 487 shares, generating $121,872 in total proceeds. Upon selling the shares at $250.25, the Director now owns 5,319 shares.
Before that, Peter C Farrell bought 2,000 shares. Resmed Inc shares valued at $504,100 were divested by the Director at a price of $252.05 per share.
Citigroup initiated its Resmed Inc [RMD] rating to a Buy in a research note published on September 18, 2025; the price target was $330. A number of analysts have revised their coverage, including CLSA’s analysts, who increased its forecast for the stock in early September from “a Hold” to “an Outperform”. RBC Capital Mkts also remained covering RMD and has increased its forecast on July 15, 2025 with a “an Outperform” recommendation from previously “Sector perform” rating. Morgan Stanley started covering the stock on March 19, 2025. It rated RMD as “an Overweight”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock jump 0.10% to $244.71. Over the last five days, the stock has lost -2.16%. Resmed Inc shares have risen nearly 3.94% since the year began. Nevertheless, the stocks have risen 7.01% over the past one year. While a 52-week high of $293.81 was reached on 08/22/25, a 52-week low of $199.92 was recorded on 04/07/25.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 242.85, which if violated will result in even more drops to 241.00. On the upside, there is a resistance level at 246.91. A further resistance level may holdings at 249.12.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-10-31, growing by 0.88 million shares to a total of 9.69 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 8.81 million shares. There was a rise of 9.12%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating.
